Clinical Trial Detail

NCT ID NCT03277209
Title To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Weill Medical College of Cornell University
Indications

ovary serous adenocarcinoma

pancreatic adenocarcinoma

colorectal adenocarcinoma

Therapies

Plerixafor

Age Groups: adult senior

No variant requirements are available.